Why Liontown (ASX:LTR) Shares Are Under Press Today? - Kalkine
Why Liontown (ASX:LTR) Shares Are Under Press Today? Kalkine
Latest articles and price-sensitive announcements with AI sentiment classification.
Why Liontown (ASX:LTR) Shares Are Under Press Today? Kalkine
Should Liontown Resources (ASX:LTR) Be on Your Lithium Watchlist? Kalkine
Broker Says “Buy” on Liontown (ASX:LTR) – Here’s Why Kalkine

Highlights Self-funded shift marks a major operational milestone China demand fuels lithium market revival Underground transition supports long-term output goals Liontown Resources advances into a self-funded phase while strengthening its lithium operations, supported by rising demand trends and strategic project optimisation. Liontown’s Self-Funded Leap Signals Lithium Strength Liontown Resources (ASX:LTR) has entered a new phase of growth, marking a key milestone as it transitio...
other announcement
Liontown (ASX:LTR) Is Up 17.9% After First Positive Net Cash Flow And Big Capex Plan – Has The Bull Case Changed? simplywall.st
Liontown (ASX:LTR) Valuation Check After Record Quarter And Shift To Underground Operations simplywall.st
We Think LTR Pharma (ASX:LTP) Can Afford To Drive Business Growth simplywall.st

Highlights SPONTAN data shows rapid onset profile Dual US regulatory pathway outlined Strong funding supports near-term milestones LTR Pharma advances its intranasal therapy with encouraging clinical data and a clear US expansion roadmap, backed by solid funding and growing real-world validation. LTR Pharma Strengthens Position with SPONTAN Progress LTR Pharma (ASX:LTP) has drawn attention following the release of encouraging interim clinical data for its SPONTAN therapy, alongside a cl...

LTR Pharma receives positive SPONTAN Phase II data ... Read More The post LTR Pharma’s SPONTAN ED nasal spray delivers rapid onset as Phase II data supports broad use appeared first on Stockhead.

other announcement

Liontown starts early works on its Kathleen Valley project, committing up to $77 million before the final investment decision. The post Liontown shares: Expansion works begin at Kathleen Valley appeared first on The Motley Fool Australia.
other announcement
Liontown Shares (ASX:LTR) Hit Multi-Year High on Breakout Rally thebull.com.au

Highlights Revenue growth reflects operational ramp-up Losses widen amid expansion phase Market focus shifts to cost control Liontown’s latest update highlights strong revenue momentum alongside rising losses, bringing attention to cost management, funding outlook, and execution strength during its lithium expansion journey. Understanding Liontown’s Latest Financial Shift (LTR) Liontown Limited (ASX:LTR) has recently delivered a financial update that reflects both progress a...

Highlights Strong revenue expansion alongside widening losses Lithium project ramp-up intensifies cost pressures Market attention centers on operational scaling dynamics Liontown developments within the ASX 200 show strong lithium sales growth paired with increased costs, reflecting project expansion and shifting dynamics across the broader resource market. Liontown Limited operates within the lithium mining and battery materials sector, supplying resources essential to energy storage and ele...
Liontown (ASX:LTR) Is Down 8.2% After Surging Revenue But Deepening Half-Year Losses - What's Changed simplywall.st

Highlights Revenue expansion draws market attention Rising loss keeps profitability debate alive Valuation views remain sharply divided Liontown’s latest update reflects strong revenue traction alongside continued losses, leaving valuation perspectives split between growth optimism and cautious cash flow outlook. The latest update from Liontown Resources Limited (ASX:LTR) has sparked renewed discussion across the mining and lithium sector, particularly among those tracking develop...
A Look At Liontown (ASX:LTR) Valuation After Half Year Revenue Growth And Wider Net Loss simplywall.st
Liontown (ASX:LTR) Valuation Check As Underground Shift And Expansion Plans Offset Wider Half Year Loss simplywall.st

Let's see what this lithium miner reported today. The post Liontown shares drop on $184m half-year loss appeared first on The Motley Fool Australia.

LTR Pharma is poised to progress the Phase II clinical study for its SPONTAN rapid-acting intranasal spray for the treatment ... Read More The post LTR Pharma takes SPONTAN Phase II study to its climax after completing recruitment appeared first on Stockhead.
other announcement
other announcement
other announcement